In these episode, we continue our conversation around novel antimicrobials. We'll delve into how these drugs are changing clinical practice, what stewardship looks like in this era, and how to balance access with responsibility.

We'll cover when to reach for these agents, when to hold back, and how they fit into the ever-evolving landscape of bacterial infections, invasive fungi, and tricky antivirals. So whether you're on service, prepping for rounds, or just curious about what's lurking in the pipeline, you're in the right place. Listen in to learn more.